loading
Precision Biosciences Inc stock is traded at $4.62, with a volume of 61,897. It is down -2.74% in the last 24 hours and up +11.86% over the past month. Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
See More
Previous Close:
$4.75
Open:
$4.7
24h Volume:
61,897
Relative Volume:
0.25
Market Cap:
$51.23M
Revenue:
$52.29M
Net Income/Loss:
$-73.52M
P/E Ratio:
-7.00
EPS:
-0.66
Net Cash Flow:
$-100.45M
1W Performance:
-10.29%
1M Performance:
+11.86%
6M Performance:
-7.78%
1Y Performance:
-51.72%
1-Day Range:
Value
$4.53
$4.78
1-Week Range:
Value
$4.53
$5.21
52-Week Range:
Value
$3.61
$11.09

Precision Biosciences Inc Stock (DTIL) Company Profile

Name
Name
Precision Biosciences Inc
Name
Phone
919-314-5512
Name
Address
302 EAST PETTIGREW STREET, DURHAM, NC
Name
Employee
107
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
DTIL's Discussions on Twitter

Compare DTIL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
DTIL
Precision Biosciences Inc
4.62 52.67M 52.29M -73.52M -100.45M -0.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-10-25 Upgrade BMO Capital Markets Market Perform → Outperform
Apr-30-24 Initiated Guggenheim Buy
Jun-17-22 Initiated BMO Capital Markets Outperform
Jun-09-22 Downgrade William Blair Outperform → Mkt Perform
Jul-27-20 Resumed BTIG Research Buy
Apr-03-20 Downgrade Goldman Buy → Neutral
Mar-05-20 Initiated Stifel Buy
Feb-25-20 Initiated William Blair Outperform
Aug-09-19 Initiated BTIG Research Buy
Jul-16-19 Initiated H.C. Wainwright Buy
Apr-22-19 Initiated Barclays Overweight
Apr-22-19 Initiated Goldman Buy
Apr-22-19 Initiated JP Morgan Overweight
Apr-22-19 Initiated Jefferies Buy
View All

Precision Biosciences Inc Stock (DTIL) Latest News

pulisher
Aug 01, 2025

Should I hold or sell Precision BioSciences Inc. stock in 2025Real Time Tracker For Fast Growth - jammulinksnews.com

Aug 01, 2025
pulisher
Jul 31, 2025

Is Precision BioSciences Inc. stock overvalued or undervaluedFree Stock Target Finder With Proven Results - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Does Precision BioSciences Inc. stock perform well during market downturnsRetirement Planning Forecasts For Consistent Profits - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 15:58:11 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Why Precision BioSciences Inc. stock attracts strong analyst attentionFast Return Equity Trade Forecast Points to Small Caps - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Precision BioSciences Inc. Stock Lags Behind Sector BenchmarksReal Time Trade Opportunity Alerts Monitor Market Surges - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Precision BioSciences Inc. stockMarket Forecast Opportunities Backed By Experts - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive Precision BioSciences Inc. stock higher in 2025Financial News Forecasts For Smart Trading - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Precision BioSciences Inc.Explosive capital appreciation - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Precision BioSciences Inc. in the next 12 monthsInvest confidently with proven investment plans - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are Precision BioSciences Inc. company’s key revenue driversBuild wealth steadily with expert advice - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is Precision BioSciences Inc. company’s growth strategyDiscover dynamic stocks ready to soar - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Precision BioSciences Inc. stock performs during market volatilityInvestor Favorite Picks - metal.it

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Precision BioSciences Inc. stock priceDynamic investment opportunities - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Precision BioSciences Inc. stockOver 200% growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Precision BioSciences shares climb after FDA grants orphan drug status - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD - Contract Pharma

Jul 23, 2025
pulisher
Jul 23, 2025

Precision Biosciences’ PBGENE-DMD gains US orphan drug designation - BioWorld MedTech

Jul 23, 2025
pulisher
Jul 23, 2025

Precision BioSciences stock rises after FDA grants orphan drug status By Investing.com - Investing.com Canada

Jul 23, 2025
pulisher
Jul 23, 2025

FDA Grants Orphan Drug Designation to Precision BioSciences' PBG - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

FDA grants orphan drug status to Precision BioSciences’ DMD treatment By Investing.com - Investing.com Canada

Jul 23, 2025
pulisher
Jul 23, 2025

FDA grants orphan drug status to Precision BioSciences’ DMD treatment - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy - Business Wire

Jul 23, 2025
pulisher
Jul 22, 2025

Precision BioSciences Shares Surge Following FDA Rare Pediatric Disease Designation - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

Precision BioSciences Inc. Stock Analysis and ForecastFree Capital Growth Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Precision BioSciences Secures Orphan Drug Designation for DMD Treatment, DTIL Stock News - AInvest

Jul 19, 2025
pulisher
Jul 17, 2025

Precision BioSciences Duchenne muscular dystrophy treatment gets orphan status - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Precision BioSciences gets FDA orphan drug designations for DMD treatment By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 16, 2025

Precision BioSciences reports promising DMD gene editing results By Investing.com - Investing.com Canada

Jul 16, 2025
pulisher
Jul 16, 2025

Precision BioSciences Highlights New Preclinical Data for PBGENE-DMD Further Supporting Advancement of Novel Gene Editing Approach for the Treatment of Duchenne Muscular Dystrophy Towards Clinic - Business Wire

Jul 16, 2025

Precision Biosciences Inc Stock (DTIL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):